SPEAKERS

Andy Whitman is the Lead Clinical Pharmacist in hematology/oncology and PGY2 oncology pharmacy program director at the University of Virginia Health in Charlottesville, VA. He completed a combined Doctor of Pharmacy degree and Certificate of Aging Studies at Virginia Commonwealth University School of Pharmacy. Dr. Whitman completed his postgraduate training at the University of Virginia Health System in oncology pharmacy followed by a year as a palliative care specialist at the University of Maryland Baltimore Washington Medical Center. His current research interests include anti-cancer therapy toxicity management, deprescribing non-essential therapies in older adults with cancer, and innovative approaches to supportive care (specifically, the potential uses of cannabis and psychedelics in cancer care).

Benyam Muluneh, PharmD., BCOP, CPP received his doctor of pharmacy at the UNC Eshelman School of Pharmacy and completed both PGY1 (Pharmacy Practice) and PGY2 (Hematology/Oncology) residencies at UNC Medical Center.  After residency, he practiced full time as a clinical pharmacist practitioner where he and his team established a pharmacist-led oral chemotherapy program which was designated with an ASHP Best Practice Award in 2015. Muluneh has since co-authored the 2018 Hematology/Oncology Pharmacist Association (HOPA) Best Practices for the Management of Oral Oncolytic Therapy and the 2022 Oncology Nursing Society’s Guidelines to Support Patient Adherence to Oral Anticancer Medications.

Muluneh joined DPET in July 2019 as a full time assistant professor. His ongoing research endeavors include: 1) Develop strategies to improve medication adherence in clinical practice; 2) Optimize tolerability and safety of chemotherapy in cancer patients; and 3) Promote chemotherapy access and affordability to underinsured and uninsured cancer patients in the United States and beyond. He also teaches in the PharmD curriculum and has a passion for international health. He is the co-director of the UNC-Ethiopia Alliance and serves as a preceptor for one of the Global Pharmacy Scholar (GPS) experiences to Ethiopia. with cancer and multiple comorbidities, and oral anticancer agents.

Kristen T. Peterson, PharmD, BCOP completed her pharmacy education at the University of Iowa College of Pharmacy in Iowa City, IA. Immediately after, Dr. Peterson completed a PGY1 Pharmacy Residency at Mayo Clinic Hospital in Rochester, Minnesota and subsequently completed a PGY2 Oncology Pharmacy Residency at Memorial Sloan Kettering Cancer Center in New York, New York. After completing residency in 2019, Dr. Peterson began working as a Clinical Oncology Pharmacist at Duke University Hospital and is now the Multiple Myeloma Clinic Pharmacist at the Duke Blood Cancer Center in Durham, NC. In this role, she optimizes patient care for myeloma, amyloid, and stem cell transplant patients in an interprofessional setting. In addition to her clinical work and research within this realm, Dr. Peterson remains actively involved in the pharmacy residency programs at Duke as both a PGY1 and PGY2 Oncology Residency Coordinator. Dr. Peterson remains an active member of the Hematology/Oncology Pharmacy Association (HOPA), the International Cardio-Oncology Society, the University of Iowa College of Pharmacy Genesis Board, and the North Carolina Oncology Pharmacists Association (NCOP). When not working, she loves to volunteer with Make-A-Wish of Eastern North Carolina and the Ronald McDonald House.

Don Moore, PharmD is the Clinical Oncology Pharmacy Manager and a practice hematology clinical pharmacist at Atrium Health’s Levine Cancer Institute in Charlotte, NC. He graduated from the Massachusetts College of Pharmacy and Health Sciences in Boston, Massachusetts and completed a PGY-1 residency at Steward St. Elizabeth’s Medical Center in Boston, MA. Dr. Moore served as faculty for the ASHP Certificate Program on Non-Malignant Hematology.

Olivia White, PharmD is a clinical ambulatory care pharmacist at University of Virginia Medical Center specializing in lymphoma & myeloma. She is originally from Alabama and attended University of Kentucky College of Pharmacy where she completed her pharmacy training. Subsequently, Olivia completed her PGY1 Pharmacy & PGY2 Oncology residency training at Duke University Hospital before starting her current role in the outpatient clinic. In her free time, he enjoys gardening, trying new restaurants, and cooking.

Erin Zacholski, PharmD, BCOP earned a Bachelor of Science in Biology from James Madison University in Harrisonburg, VA, followed by a Doctor of Pharmacy degree from Virginia Commonwealth University (VCU) School of Pharmacy in Richmond, VA.  She completed her PGY1 Pharmacy and PGY-2 Hematology/Oncology Pharmacy residencies at the University of Kentucky HealthCare in Lexington, KY. In 2019, Dr. Zacholski joined VCU School of Pharmacy’s faculty as an Assistant Professor of Pharmacotherapy and Outcomes Science, where she teaches didactically and experientially, conducts scholarship to improve teaching, learning, and the care of oncology patients, and serves patients at the VCU Massey Cancer Center as a Clinical Oncology Pharmacy Specialist specializing in gynecologic oncology and chronic hematologic malignancies.

Jordan Snyder, PharmD, BCOP completed pharmacy school at the University of Kansas before going to Wichita, Kansas to complete PGY-1 at Wesley Medical Center. She finished PGY-2 at the University of Kansas Health System in 2018. Jordan is currently a clinical oncology pharmacist at the University of Kansas Health System and primarily practice in the outpatient hematology clinics.